Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-84.63	-51.82	337.12
Graham Fair Price	225.83	2.14	0.66
PEG	-99.48	< 0.005	0.96
Price/Book	-13.74	2.07	2.40
Price/Cash Flow	73.46	-35.28	-132.94
Prices/Earnings	93.26	-5.22	-77.46
Price/Sales	23.68	16.72	13.52
Price/FCF	73.46	-35.28	-132.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-34.79	0.25	0.39
Operating Margin	-1376.70	-0.81	-0.05
ROA	-1073.94	-0.02	< 0.005
ROE	< 0.005	-0.10	-1179.45
ROIC	< 0.005	-0.04	-702.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	-0.09	-84.97
Dividends QOQ	-0.03	-0.11	-222.05
EBIT QOQ	0.76	-8.37	1000.69
EPS QOQ	0.81	-10.48	1197.15
FCF QOQ	-1.78	-1.96	-9.93
Revenue QOQ	0.61	-0.37	-39.80
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	142.88	258.22	80.72
Days Sales Outstanding (DSO)	138.99	363.73	161.70
Inventory Turnover	0.63	0.35	-44.67
Debt/Capitalization	0.60	0.62	4.27
Quick Ratio	0.39	0.47	18.91
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.58	1.53	-2.78
Cash	0.72	0.69	-3.83
Capex	-0.05	0.02	-48.24
Free Cash Flow	-0.03	-0.08	-196.09
Revenue	0.28	0.18	-36.47
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.69	0.59	-13.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	119.34	-21.64	-81.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating